New Jersey A4748 requires Medicaid coverage for ovulation enhancing drugs and related medical services for beneficiaries aged 21-44 experiencing.

New Jersey A4748 mandates Medicaid coverage for ovulation enhancing drugs and medical services related to administering such drugs for certain beneficiaries experiencing infertility. The bill defines infertility as the inability to conceive after 12 months of regular, unprotected intercourse for individuals aged 21-34, and six months for those aged 35-44. Covered medical services include office visits, hysterosalpingograms, pelvic ultrasounds, and blood testing. The coverage is limited to three cycles of treatment per beneficiary's lifetime.

New Jersey A4748 requires Medicaid coverage for ovulation enhancing drugs and related medical services for beneficiaries aged 21-44 experiencing.

New Jersey A4748 mandates Medicaid coverage for ovulation enhancing drugs and medical services related to administering such drugs for certain beneficiaries experiencing infertility. The bill defines infertility as the inability to conceive after 12 months of regular, unprotected intercourse for individuals aged 21-34, and six months for those aged 35-44. Covered medical services include office visits, hysterosalpingograms, pelvic ultrasounds, and blood testing. The coverage is limited to three cycles of treatment per beneficiary's lifetime.